| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0018 | 1 |